Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456).

Source:http://linkedlifedata.com/resource/pubmed/id/8261430

Cancer Res. 1994 Jan 1 54 1 114-9

Download in:

View as

General Info

PMID
8261430